RECRUITING

Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma

Description

This study aims to determine whether a blood test can help doctors decide when to use a head CT scan for patients with a mild head injury. Researchers are investigating whether the results from this blood test can aid in making better decisions about patient care and potentially reduce the need for imaging. In this study, researchers will collect blood samples to assess whether this specific blood test can help doctors decide when head imaging is necessary following a head injury. The goal is to determine whether the use of this test can reduce the number of head imaging procedures performed in the emergency department (ED).

Study Overview

Study Details

Study overview

This study aims to determine whether a blood test can help doctors decide when to use a head CT scan for patients with a mild head injury. Researchers are investigating whether the results from this blood test can aid in making better decisions about patient care and potentially reduce the need for imaging. In this study, researchers will collect blood samples to assess whether this specific blood test can help doctors decide when head imaging is necessary following a head injury. The goal is to determine whether the use of this test can reduce the number of head imaging procedures performed in the emergency department (ED).

Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma

Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma

Condition
Brain Injuries
Intervention / Treatment

-

Contacts and Locations

Atlanta

Grady Health System, Atlanta, Georgia, United States, 30303

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adults aged 18-65 years old
  • * Mild TBI, defined as Glasgow Coma Scale (GCS) score 13-15, presenting within 24 hours of injury
  • * No prior head imaging for the same incident
  • * Presenting within 24 hours of onset of injury
  • * Patients with penetrating head injury
  • * History of known brain abnormality including tumor, cerebrovascular malformation, recent brain surgery (within 6 months), prior head injury (within 6 months)
  • * Need for emergent surgical intervention for brain or alternate body organ injury
  • * Need for emergent bedside procedures for hemodynamic or orthopedic stabilization
  • * Patients deemed at higher risk for decline by the provider prohibit the 15-minute delay in obtaining imaging needed for biomarker testing.

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Emory University,

Jonathan Grossberg, MD, PRINCIPAL_INVESTIGATOR, Emory University

Study Record Dates

2026-06